About Echo IQ
Echo IQ is an Australian medical technology company that specializes in developing AI-driven solutions to enhance decision-making in cardiology. Their flagship product, EchoSolv, utilizes AI-driven analysis of echocardiographic data to assist clinicians in the early and accurate detection of structural heart diseases, such as Aortic Stenosis (AS) and Heart Failure (HF). The company’s mission is to improve patient outcomes by facilitating earlier and more precise identification of life-threatening, yet treatable, cardiac conditions.
For physicians, EchoSolv AS provides measurement-based AI clinical decision support for severe aortic stenosis probability, offering a standardized assessment and guideline check from routine echo measurements. This technology is designed to integrate seamlessly into existing workflows, requiring no electronic medical record (EMR) integration, and aims to reduce review time by assisting clinicians in reviewing studies more efficiently and ensuring high-risk cases are not overlooked. Echo IQ’s solutions are developed using extensive echocardiographic measurement datasets and are intended to complement clinician review, providing fast and precise insights into structural heart damage. The company is also engaged in research collaborations, including one with Mayo Clinic, to assess cardiac risk in patients receiving cancer therapy, expanding the potential applications of their AI platform beyond current cardiovascular diagnostics.
Focus Areas
Business Intelligence
| Technology | EchoSolv platform, AI-driven analysis of echocardiographic data, cloud-based platform |
What Physicians Need to Know
Echo IQ's EchoSolv platform can significantly enhance your ability to detect and manage structural heart diseases like aortic stenosis. It provides a 'second look' at echocardiogram measurements, offering AI-driven insights that can improve diagnostic accuracy and consistency, especially for severe cases or those at high risk. The system is designed to integrate seamlessly into your current workflow, delivering results quickly without requiring changes to your imaging solutions or hardware. This allows for more efficient review of studies and helps ensure that high-risk patients are not overlooked, ultimately supporting earlier intervention and better patient care.
EchoSolv integrates directly into existing hospital Picture Archiving and Communication Systems (PACS) without requiring Electronic Medical Record (EMR) integration. It is designed to fit existing workflows with minimal disruption. The platform can also provide data export options and PDF report generation. Echo IQ has established partnerships with leading imaging software providers and hospital networks for commercialization and integration.
What the Web Says
Echo IQ is an Australian company specializing in AI-driven solutions for cardiovascular disease detection and management. Their primary product focuses on analyzing echocardiogram data to identify patients at risk of structural heart disease, particularly aortic stenosis. While specific product reviews from major platforms like G2, Capterra, and Reddit are limited, the company has received positive attention in healthcare IT news for its innovative approach and potential to improve patient outcomes. Employer reviews are not readily available on Glassdoor or similar platforms.
Overall: PositiveStrengths
- Innovative AI-driven approach to cardiovascular disease detection.
- Potential to significantly improve early diagnosis of conditions like aortic stenosis.
- Focus on a critical area of healthcare with high unmet need.
- Partnerships with major healthcare providers and research institutions.
- Strong clinical validation for their technology.
- Aims to reduce healthcare costs and improve patient pathways.
Limitations
- Limited public product reviews from major platforms (G2, Capterra).
- Lack of readily available employer reviews on platforms like Glassdoor.
- Adoption challenges inherent in introducing new AI technologies into clinical workflows.
- Reliance on high-quality echocardiogram data for optimal performance.
- Potential for regulatory hurdles in different markets.
- Specific pricing and implementation details are not widely publicized.
Based on reviews from: Healthcare IT News, Company Website (Echo IQ), Clinical Trial Registries, Industry Analyst Reports (limited public access)
Last updated: 2026-10-23
Videos
News, demos, and interviews about Echo IQ.
Videos load interactively. If none appear, search YouTube for Echo IQ →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]
The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]
Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]
PHQ Screeners is a free, open-access resource maintained by Pfizer, providing a comprehensive suite of Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments. These tools were developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke with an educational grant from Pfizer, and are widely utilized in primary care and […]
NeurixaHealthAI™ is a healthcare AI company dedicated to eliminating administrative waste in the healthcare system, which they estimate to be $1.1 trillion annually. They offer a production-ready healthcare intelligence platform designed to simplify operations, improve outcomes, and accelerate the journey from patient care to financial performance. The platform is not a collection of point solutions […]